Apni Pathshala

India Snakebite Crisis

India Snakebite Crisis

General Studies Paper II: Government Policies & Interventions 

 

Why in News? 

Recently, the Union government informed Parliament that 431 people died from snakebites across India last year, a rise from 370 in 2024 and 183 in 2023.

India Snakebite Crisis

Burden of Snakebite in India

    • National Burden: India bears the highest global burden of snakebite deaths, accounting for nearly 50% of worldwide mortality. Estimates suggest around 45,000–58,000 deaths annually, making it a major but under-recognized public health crisis.
    • Mortality Trends: Between 2000–2019, India recorded approximately 1.2 million snakebite deaths, averaging ~58,000 deaths per year. This highlights the persistent and structural nature of the crisis rather than a temporary health issue.
    • Rural Dominance: Around 97% of snakebite deaths occur in rural areas, especially in agricultural communities. This reflects the strong link between livelihood patterns (farming, barefoot work) and exposure to venomous snakes.
      • India’s agrarian structure is the most significant driver, with 60–70% of snakebite cases linked to agricultural activities like paddy cultivation and field work.
    • Demographic Vulnerability: The burden is disproportionately borne by the economically productive age group (30–69 years) and children (<15 years). This leads to loss of workforce and long-term socio-economic impacts on families.
    • Regional Cases: States like Uttar Pradesh, Bihar, Madhya Pradesh, Odisha, Rajasthan, Andhra Pradesh account for nearly 70% of deaths, indicating geographical clustering in low-altitude, densely populated regions.
      • Karnataka recorded the highest such deaths (157) in 2025 and 101 in 2024.
    • Seasonal Patterns: Snakebite incidence peaks during the monsoon season (June–September) due to flooding, agricultural activity, and increased human-snake interaction, making it a seasonally intensified disaster.
      • India’s tropical and subtropical climate supports over 300 snake species (60+ venomous), increasing the probability of encounters. 
    • Venomous Species: Nearly 90% of fatal snakebites are caused by the “Big Four” species—Indian cobra, common krait, Russell’s viper, and saw-scaled viper—highlighting the predictable yet deadly nature of envenomation patterns.
  • Non-Fatal Burden: Snakebites cause permanent disabilities, amputations, kidney failure, and neurological damage, contributing to long-term health burden and DALYs (Disability Adjusted Life Years). Globally, 400,000 people suffer such outcomes annually, many from India. 

Healthcare Challenges in Snakebite Management in India

  • Limited Access: A major challenge is poor geographical access to healthcare facilities in rural India, where most snakebites occur. Many victims fail to reach hospitals within the “golden hour”, significantly increasing mortality risk. 
  • Traditional Practices: A large proportion of victims initially approach traditional healers, causing critical delays in antivenom administration. Studies show that many cases never reach formal healthcare systems, contributing to high mortality.
  • Inadequate Availability: Despite being a major producer, India faces uneven distribution and shortages of anti-snake venom (ASV), especially in Primary Health Centres (PHCs). Many rural facilities either lack stock or maintain insufficient quantities during peak seasons. 
  • Lack of Trained Personnel: Healthcare workers often lack specialized training in snakebite management, including correct dosage, identification of symptoms, and management of complications. This leads to inconsistent treatment protocols across facilities. 
  • Weak Response Systems: The referral chain from primary to tertiary care is inefficient, with many patients being shifted multiple times. Peripheral centers lack ICU support, ventilators, and resuscitation facilities, worsening outcomes during severe envenomation.
  • Affordability Barriers: Although antivenom is on the WHO Essential Medicines List, its cost and associated hospitalization expenses impose catastrophic financial burdens. Many families incur debt or sell assets to afford treatment.

Government Initiatives and Global Commitments 

  • Recognition as NTD: Snakebite envenoming was officially classified as a Neglected Tropical Disease (NTD) by the World Health Organization (WHO) in 2017, bringing global attention and funding priorities. This recognition positioned snakebite within public health and development agendas.
  • Snakebite Strategy (2019–2030): The WHO launched a global roadmap aiming to reduce snakebite deaths and disabilities by 50% by 2030. It focuses on safe antivenom access, community awareness, and strengthening health systems, guiding India’s national policies.
  • WHO South-East Asia Regional Action Plan (2022–2030): India aligns with the regional strategy targeting high-burden countries, emphasizing cross-border collaboration, surveillance, and capacity building. 
  • UN SDG Goal: Snakebite management is now aligned with UN SDG Goal 3, which focuses on ensuring healthy lives. By reducing the 391,979 DALYs (Disability-Adjusted Life Years) lost to snakebites, nations move closer to universal health coverage. 
  • National Programme for Prevention and Control of Snakebite Envenoming: India has institutionalized a dedicated programme under the Ministry of Health & Family Welfare, aiming to reduce mortality and morbidity through better treatment access, training, and awareness. 
  • National Action Plan for Snakebite (NAPSE): Launched in March 2024, this comprehensive plan focuses on universal access to antivenom, health system strengthening, and inter-sectoral coordination. It allows state-specific strategies under a One Health approach
  • Community Awareness and Campaigns: The government promotes Information, Education, and Communication (IEC) campaigns to spread awareness about prevention, first aid, and early hospital treatment, especially in high-risk rural areas.
  • Research and Development Initiatives (ICMR): The Indian Council of Medical Research (ICMR) has launched a ₹13.5 crore multi-state project (2025) to develop a scalable model for snakebite reduction, based on successful local interventions like the Assam Demow Model
  • One Health and Multi-Sectoral Approach: India’s strategy integrates human health, animal health, and environmental sectors under the One Health framework, ensuring coordination between health, forest, agriculture, and local governance institutions.
  • Snakebite Helpline: A dedicated Snakebite Helpline (15400) was piloted in five Indian states (including Assam and Delhi) in 2024. This service provides immediate first-aid guidance and directs victims to the nearest treatment centre.

Assam Demow Model:

  • Origin: The Demow Model originated in Sivasagar district, Assam, a high snakebite-burden region. It was developed at a Rural Community Health Centre (CHC) to address frequent fatalities in underserved rural populations.
  • Launch: The model began in 2018 as a localized intervention and evolved into a comprehensive, protocol-driven system for snakebite prevention and treatment at the grassroots level. 
  • Achievement: A key success is “Zero Snakebite Deaths” for 4–5 consecutive years (2021–2025), a rare achievement in rural India, demonstrating high treatment efficiency.
    • In 2024, the centre treated 863 snakebite cases, including 146 venomous bites, with zero deaths, showcasing robust clinical capacity. 
    • Assam reported around 11,000 snakebite cases and 36 deaths in 2024, highlighting how Demow significantly outperformed state averages in mortality reduction. 
  • Community-Centric: The model emphasizes strong community engagement, with awareness campaigns and local participation, ensuring early reporting and reducing delays. 
    • It uses trained local volunteers as first responders who facilitate rapid transport and referral, bridging the gap between victims and healthcare facilities.
  • Treatment Protocol: The model follows a uniform clinical protocol involving early ASV administration, 24-hour observation, and syndrome-based treatment, ensuring consistent care quality. 
    • Unlike traditional systems, it proves that effective snakebite treatment is possible at PHC/CHC level, reducing dependence on tertiary hospitals.
  • Significance: Demow is now considered a replicable, low-cost, community-driven model, forming a core pillar of India’s “Zero Snakebite Death Initiative”, with potential nationwide adoption. 

 

Also Read: World Longest Snake Discovered in Indonesia

 

Share Now ➤

Do you need any information related to Apni Pathshala Courses, RNA PDF, Current Affairs, Test Series and Books? Our expert counselor team will not only help you solve your problems but will also guide you in creating a personalized study plan, managing time and reducing exam stress.

Strengthen your preparation and achieve your dreams with Apni Pathshala. Contact our expert team today and start your journey to success.

📞 +91 7878158882

Related Posts

Scroll to Top